New appointments to UCL’s senior management team

Professor Stephen Caddick, Head of UCL Chemistry, will succeed Professor Mike Spyer as Vice-Provost (Enterprise) upon Professor Spyer's retirement on 1 May 2010. In the role of Vice-Provost (Enterprise), Professor Caddick will be responsible for leading UCL's enterprise agenda, which specifically entails raising the profile of entrepreneurial activities; promoting academic and industry liaison; maximising revenue from the commercialisation of research technology; the capitalisation of intellectual property; and establishing and developing spin-out companies and clinical trial activities, among other duties. Professor Caddick is Head of UCL Chemistry and Director of the Centre for Chemical Biology at UCL. He has a major research group in Organic Synthesis and Chemical Biology, with a particular focus on the development of novel and sustainable synthetic methods for applications in biological and biomedical research. He led the development of the UCL Chemistry Drug Discovery PhD programme, is part of the group that bid successfully for a Wellcome Trust Interdisciplinary PhD programme and a member of the team that attracted a Wellcome Trust award to develop a treatment for septic shock. He is currently playing a key role in developing the unique contribution UCL will make to the UK Centre for Medical Research & Innovation (UKCMRI), which will bring the university together with three other world-leading biomedical research organisations (Cancer Research UK, the Medical Research Council and the Wellcome Trust) in central London to undertake cutting-edge research and to train of medical scientists to advance the understanding of health and disease.